Most investors passed on Atomic Alchemy because it was a nuclear reactor. Full stop. While they chased software margins, we saw a founder living inside the biggest bottleneck in nuclear.
The Constraint Nobody Wanted
The nuclear medicine market in 2019 was broken: only 7 aging reactors worldwide produced medical isotopes—